MoneyWorks4Me

Ajanta Pharma - Quaterly Results

30 Jul 2024 Evaluate
The company witnessed a 6.18% growth in the revenue at Rs. 10772.70 millions for the quarter ended June 2024 as compared to Rs. 10145.80 millions during the year-ago period.A slim rise of 11.31% was recorded in the Net profit for the quarter ended June 2024 to Rs. 2360.30  millions  From Rs. 2120.40 millions.Operating profit for the quarter ended June 2024 rose to 3442.00 millions as compared to 3083.60 millions of corresponding quarter ended June 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 10772.70 10145.80 6.18 10772.70 10145.80 6.18 39711.20 34112.70 16.41
Other Income 283.70 314.60 -9.82 283.70 314.60 -9.82 1164.80 1327.50 -12.26
PBIDT 3442.00 3083.60 11.62 3442.00 3083.60 11.62 12359.10 8320.30 48.54
Interest 7.20 7.50 -4.00 7.20 7.50 -4.00 68.00 52.30 30.02
PBDT 3434.80 3076.10 11.66 3434.80 3076.10 11.66 12291.10 8268.00 48.66
Depreciation 329.20 322.40 2.11 329.20 322.40 2.11 1321.60 1269.50 4.10
PBT 3105.60 2753.70 12.78 3105.60 2753.70 12.78 10969.50 6998.50 56.74
TAX 745.30 633.30 17.69 745.30 633.30 17.69 2897.10 1411.30 105.28
Deferred Tax 31.10 27.50 13.09 31.10 27.50 13.09 121.30 -29.30 -513.99
PAT 2360.30 2120.40 11.31 2360.30 2120.40 11.31 8072.40 5587.20 44.48
Equity 250.70 252.70 -0.79 250.70 252.70 -0.79 252.70 252.70 0.00
PBIDTM(%) 31.95 30.39 5.13 31.95 30.39 5.13 31.12 24.39 27.60
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..